You are what you eat! So how does the Mediterranean diet affect the gut? *maintaining/shaping healthy gut microbiota *enhancing anti-inflammatory metabolite production *maintaining intestinal barrier integrity Dr. M. Guma #RNL2024 @RheumNow https://t.co/O9by7CahRW

How does the Mediterranean diet affect inflammation? Dr. Guma noted the diet helps to: 1. maintain healthy microbiota 2. enhance production of anti-inflammatory metabolites 3. maintain intestinal barrier integrity. #RNL2024 @rheumnow https://t.co/d3ByStvXyR

Dr. M Guma noted @ACRheum 2022 Guidelines on RA recommend the #MediterraneanDiet; studies have shown this diet reduces CV risk, RA disease activity #RNL2024 @RheumNow https://t.co/AdKWgME4nD

#RNL2024 @RheumNow 2022 ACR Guideline for Integrative Interventions for RA - Conditionally recommend Mediterranean diet - Conditionally recommend Against other diets or dietary supplements *Low or very low to moderate evidence due to absence of good studies 🍇🫒 https://t.co/PkZ9ovQ1ON

#Cardiorheumatology is an emerging, important field; contact Dr. Weber if interested in learning more. #RNL2024 @Rheumnow https://t.co/WhMlC7AtHU

#RNL2024 @RheumNow ASCVD Risk Calculators underestimate risk in patients of RA Inflammatory disease was added as a "risk enhancer" in 2019 update "A low ASCVD and/or absence of symptoms may be not be reassuring" https://t.co/XjTuzvvO4v

Why is improved plaque identification important? 1. Most stress tests are normal! 2. Most events occur in pts with normal function studies 3. Plaque burden predicts risk, better than stenosis Dr. B. Weber #RNL2024 @RheumNow https://t.co/Qs19qIYj5v

ICYMI: new guidelines published in 2019 for CV prevention. It's important to assess CV risk in our patients because inflammatory diseases is now included as a risk factor (helps when deciding on starting pts on JAKi)- Dr. B Weber #RNL2024 @RheumNow https://t.co/nBQjs49avu https://t.co/apyDjaxudi

Primary ASCVD Prevention Guidelines for your reference from Dr. B. Weber. #RNL2024 @RheumNow https://t.co/erxIgeeLNU

Dr. B. Weber's review of the 2019 ASCVD risk factors which now includes inflammatory diseases (RA, HIV, PsO). She believes this will help us to better understand and grow our knowledge around patient risk. @RheumNow #RNL2024 https://t.co/9bV7VfExNf